Sriraam Kalingarayar, Amar Nandhakumar, Arumugam S Thennavan
Indian Journal of Anaesthesia 2017 61(12):1009-1011
The introduction of new chemotherapeutic agents for the treatment of multiple myeloma (MM) has improved the life expectancy and quality of life for these patients in the last decade. Therefore, more patients with MM are being treated for repeated pathological fractures. The anaesthesiologist should continue the optimum supportive care received by these patients in the perioperative period also, by understanding the pathophysiology of the disease, the adverse effects of the chemotherapeutic agents and the guidelines for their supportive care. We report the perioperative management of a patient with MM and discuss the perioperative anaesthetic considerations.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nY65Ca
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Assessment of water quality status of a river with respect to its discharge has become prerequisite to sustainable river basin man...
-
Viruses, Vol. 10, Pages 61: Virus–Bacteria Interactions: Implications and Potential for the Applied and Agricultural Sciences Viruses doi: ...
-
by Alison M. Hixon, Guixia Yu, J. Smith Leser, Shigeo Yagi, Penny Clarke, Charles Y. Chiu, Kenneth L. Tyler In 2014, the United States exp...
-
Related Articles Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque p...
-
Accumulating data have indicated that citrus polymethoxyflavones (PMFs) have the ability to affect brain function. In the present study, we ...
-
No large-scale, head-to-head, phase III, randomized, controlled trial with an adequate sample size has investigated the effect of concurrent...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου